Rubin Steven D
Transaction: 07/24/2026
SELL
Change
-53,266
Price
$1.22
Filing
07/28/2026
Type
SELL
OPKO Health, Inc.
OPK • Biotechnology
$1.64
— 0.00 (0.00%)
EarningsLatest report: Jun 30, 2026
HIGHER-RISK PROFILECautionConfidence: 70%
Quantitative profile — not an investment recommendation.
Quantitative profile — not an investment recommendation.Methodology
Analysis thesis: Caution is warranted. Recent ratios show weaknesses that may limit returns unless fundamentals improve.
Market Cap
$1.24B
Growth
13.2%
Cash Flow
1/5
Trend
Volatile
Evidence
Manageable debt level · 0.34Healthy liquidity · 3.97Negative growth trendWeak profitability
Financial data as of: Jun 30, 2026, 12:00 AM UTCLast earnings update: Jun 30, 2026, 12:00 AM UTCLast profile update: Aug 5, 2026, 2:27 PM UTC
Company Snapshot
Key valuation, quality, financial strength, momentum and analyst data.
Price$1.64
Change0.00%
Shares Out757.06M
Market Cap$1.24B
Enterprise Value$1.10B
52W Range0.98 - 1.73
Beta1.48
P/E-17.03
P/S2.11
P/B1.05
P/FCF-9.26
EV/Sales1.88
Price$1.64
Change0.00%
Shares Out757.06M
Market Cap$1.24B
Enterprise Value$1.10B
52W Range0.98 - 1.73
Beta1.48
P/E-17.03
P/S2.11
P/B1.05
P/FCF-9.26
EV/Sales1.88
EV/EBITDA-13.37
EV/FCF-8.23
Earnings Yield-5.87%
FCF Yield-10.79%
Dividend Yield0.00%
Gross Margin21.10%
Oper. Margin-36.08%
Profit Margin-37.19%
Debt/Eq0.34
Current Ratio3.97
Quick Ratio3.52
Revenue 5Y13.19%
Target$2.87
Target Upside75.00%
Target Median$3.00
Target Range1.60 - 4.00
Volume3.20M
Avg Volume3.45M
EPS Surprise0.00
Investment DNA
How strong this company looks for long-term investors
44
out of 100
Business Quality
Margins, moat, returns
22/100
Financial Strength
Debt, cash, stability
75/100
Growth Potential
Revenue and expansion
20/100
Price Attractiveness
Cheap or expensive today
93/100
Why this score▼
Manageable debt level · 0.34Healthy liquidity · 3.97Negative growth trendWeak profitability
Analyst view
Analyst sentiment and price target
Analyst sentiment
Based on 13 analyst votes · 2026-09-05
77/100
Bullish
Bullish
8
Hold
4
Bearish
1
Price Target
2026-07-31
Low
$1.60
Mean
$2.87
Median
$3.00
High
$4.00
Insider Transactions
Recent executive and insider activity
⚠ 1 high-volume insider sell detected
Logal Adam
Transaction: 07/24/2026
SELL
Change
-53,266
Price
$1.22
Filing
07/28/2026
Type
SELL
Yu Alice Lin-Tsing
Transaction: 06/18/2026
BUY
Change
+30,000
Price
$1.42
Filing
06/22/2026
Type
BUY
| Insider | Type | Change | Price | Transaction | Filing |
|---|---|---|---|---|---|
| Rubin Steven D | SELL | -53,266 | $1.22 | 07/24/2026 | 07/28/2026 |
| Logal Adam | SELL | -53,266 | $1.22 | 07/24/2026 | 07/28/2026 |
| Yu Alice Lin-Tsing | BUY | +30,000 | $1.42 | 06/18/2026 | 06/22/2026 |
| UPPALURI SUBBARAO V | BUY | +80,000 | $1.42 | 06/18/2026 | 06/22/2026 |
| PFENNIGER RICHARD C JR | BUY | +60,000 | $1.42 | 06/18/2026 | 06/22/2026 |
| PAGANELLI JOHN A | BUY | +30,000 | $1.42 | 06/18/2026 | 06/22/2026 |
| MEDEL ROGER MD | BUY | +30,000 | $1.42 | 06/18/2026 | 06/22/2026 |
| Lachman Prem A | BUY | +30,000 | $1.42 | 06/18/2026 | 06/22/2026 |
| PAGANELLI JOHN A | BUY | +10,000 | $1.14 | 03/20/2026 | 03/20/2026 |
| UPPALURI SUBBARAO V | OTHER | 0 | Not reported | 03/18/2026 | 03/20/2026 |
| UPPALURI SUBBARAO V | BUY | +50,000 | $1.17 | 03/18/2026 | 03/20/2026 |
| FROST PHILLIP MD ET AL | BUY | +102,371 | $1.30 | 11/21/2025 | 11/21/2025 |
| FROST PHILLIP MD ET AL | BUY | +119,129 | $1.32 | 11/20/2025 | 11/20/2025 |
| FROST PHILLIP MD ET AL | BUY | +36,325 | $1.28 | 11/19/2025 | 11/19/2025 |
| FROST PHILLIP MD ET AL | BUY | +410 | $1.25 | 11/18/2025 | 11/18/2025 |
| FROST PHILLIP MD ET AL | BUY | +150,000 | $1.42 | 10/31/2025 | 10/31/2025 |
| FROST PHILLIP MD ET AL | SELL | -440,000 | Not reported | 08/18/2025 | 08/19/2025 |
| FROST PHILLIP MD ET AL | BUY | +675,000 | $1.32 | 08/08/2025 | 08/08/2025 |
| Nabel Gary J. | BUY | +437,500 | $1.31 | 05/27/2025 | 05/29/2025 |
| Logal Adam | BUY | +437,500 | $1.31 | 05/27/2025 | 05/29/2025 |